Results
Thyrocare Q2 Revenue Up 25.1% with 61.6M Tests Processed
Thyrocare reported Q2FY27 consolidated revenue growth of 25.1% YoY to ₹270.8 crore driven by 26.7% pathology segment growth.
PAT before exceptional items grew 25.7% YoY to ₹60.2 crore despite a ₹45 cr
